High-Speed Atomic Force Microscopy Reveals Disordered Region-Mediated Structural Plasticity of Anaplastic Lymphoma Kinase Fusion Proteins Induced by Inhibitors
EML4-ALK is a key oncogenic driver in lung cancer, but variant-specific chemoresistance limits the efficacy of current ALK inhibitors. Because the N-terminus contains an intrinsically disordered region (IDR), how ALK inhibitors affect the structure and dynamics of full-length EML4-ALK remains unclear. Here, using high-speed atomic force microscopy (HS-AFM), we visualize the overall structures of three full-length EML4-ALK variants (v1, v3, and v5) at the single-molecule level. We identified a transient globular subdomain (residues 191-217) within the v3 IDR that contributes to distinct oligomerization patterns. Notably, ALK inhibitors compact the IDR subdomain and reduce oligomerization, whereas this effect is abolished by the resistance mutation ALK<sup>G1202R</sup>, suggesting that ALK inhibitors not only inhibit kinase activity but also modulate IDR dynamics. Our study reveals a structural basis linking IDR dynamics to variant-specific oligomerization in EML4-ALK, offering further insights into the regulation of oncogenic signaling and the development of targeted therapies.
Authors
- Neval Yilmaz
- Noriyuki Kodera (ORCID: https://orcid.org/0000-0003-4880-8423)
- Dominic Chih‐Cheng Voon (ORCID: https://orcid.org/0000-0002-2963-9305)
- Holger Flechsig (ORCID: https://orcid.org/0000-0003-4984-9294)
- Bonan Li (ORCID: https://orcid.org/0009-0009-2453-1344)
- Xujun Han (ORCID: https://orcid.org/0000-0002-4049-4039)
- Sachiko Arai
- Koji Fukuda
- Hiroyuki Mano
- Seiji Yano
- Ryu Imamura
- Katsuya Sakai
- Kunio Matsumoto
- Shigeki Nanjo
Institutions
- Kanazawa University (JP)
- Cancer Institute (WIA) (IN)
- Innovative Medicines Initiative (BE)
- Institute of Cancer Research (CA)
- Life Science Institute (JP)
- Toxicologie, Pharmacologie et Signalisation Cellulaire (FR)
- National Institute of Health (AM)
- Cellular Research (United States) (US)
- National Cancer Research Institute (GB)
Publication Details
- Journal
- ACS Nano
- Published
- 2026-01-20
- DOI
- https://doi.org/10.1021/acsnano.5c17078
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00